Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
The Journal of Evidence-Based Dental Practice
|
December 19, 2006
Bisphosphonates are associated with the development of exposed bone (osteonecrosis/osteopetrosis) in the oral cavity
Cesar A Migliorati
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2003
Bisphosphanates and oral cavity avascular bone necrosis
Cesar A Migliorati
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
February 4, 2010
Commentary: Massive osteolysis or Gorham-Stout disease
Cesar A Migliorati
The Lancet. Oncology
|
May 31, 2008
Periodontal diseases and cancer
Cesar A Migliorati
The Journal of Evidence-Based Dental Practice
|
May 22, 2008
Intravenous bisphosphonate therapy may lead to osteonecrosis of the jaw in multiple myeloma, breast, and prostate cancer patients
Cesar A Migliorati
The Journal of Evidence-Based Dental Practice
|
March 10, 2009
Low incidence of osteonecrosis of the jaw in postmenopausal women with osteoporosis taking zoledronic acid once yearly
Cesar A Migliorati
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
|
May 21, 2014
The intersection of oral medicine and interprofessional education
Cesar A Migliorati, Rui Amaral Mendes
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
|
November 3, 2024
The challenge of evidence-based practice in oral diagnostic sciences
Sarah G Fitzpatrick, Cesar A Migliorati
The Journal of the Tennessee Dental Association
|
January 28, 2010
New oncology drugs and osteonecrosis of the jaw (ONJ)
Cesar A Migliorati, J Stansill Covington
Journal of the American Dental Association (1939)
|
May 3, 2008
Osteoporosis and its implications for dental patients
Beatrice J Edwards, Cesar A Migliorati
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
The Journal of Evidence-Based Dental Practice
|
December 19, 2006
Bisphosphonates are associated with the development of exposed bone (osteonecrosis/osteopetrosis) in the oral cavity
Cesar A Migliorati
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2003
Bisphosphanates and oral cavity avascular bone necrosis
Cesar A Migliorati
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
February 4, 2010
Commentary: Massive osteolysis or Gorham-Stout disease
Cesar A Migliorati
The Lancet. Oncology
|
May 31, 2008
Periodontal diseases and cancer
Cesar A Migliorati
The Journal of Evidence-Based Dental Practice
|
May 22, 2008
Intravenous bisphosphonate therapy may lead to osteonecrosis of the jaw in multiple myeloma, breast, and prostate cancer patients
Cesar A Migliorati
The Journal of Evidence-Based Dental Practice
|
March 10, 2009
Low incidence of osteonecrosis of the jaw in postmenopausal women with osteoporosis taking zoledronic acid once yearly
Cesar A Migliorati
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
|
May 21, 2014
The intersection of oral medicine and interprofessional education
Cesar A Migliorati, Rui Amaral Mendes
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
|
November 3, 2024
The challenge of evidence-based practice in oral diagnostic sciences
Sarah G Fitzpatrick, Cesar A Migliorati
The Journal of the Tennessee Dental Association
|
January 28, 2010
New oncology drugs and osteonecrosis of the jaw (ONJ)
Cesar A Migliorati, J Stansill Covington
Journal of the American Dental Association (1939)
|
May 3, 2008
Osteoporosis and its implications for dental patients
Beatrice J Edwards, Cesar A Migliorati
Page
of 5